Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical composition for treatment of duchenne muscular dystrophy

Pharmaceutical composition for treatment of duchenne muscular dystrophy

US Patent 6653466 · Granted Nov 25, 2003

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Inhibition of myostatin signal by myostatin splice variant-derived protein and u2025
Therapeutic agent for glycogen storage disease type IA2024
Nucleic acid drug for inducing skipping of variant exon of CD44 gene and increas2019
ENA nucleic acid pharmaceuticals capable of modifying splicing of mRNA precursor2017
ENA nucleic acid pharmaceuticals capable of modifying splicing of mRNA precursor2017
Readthrough inducing agent and drug for treating genetic disease caused by nonse2016
Prophylactic or ameliorating agent for genetic diseases2016
ENA nucleic acid pharmaceuticals capable of modifying splicing of mRNA precursor2016
Self-diagnosis system and test circuit determination method2014
ENA nucleic acid drugs modifying splicing in mRNA precursor2014
ENA nucleic acid drugs modifying splicing in mRNA precursor2011
Pharmaceutical composition for treatment of Duchenne muscular dystrophy2004